DRAP recall Substandard Medicines-27 June-2025
DRAP recall ⚠️Substandard Medicines⚕️-27 June-2025 The Directorate of Drug Control (DDC) Punjab has notify DRAP (drug regulatory authority of Pakistan) […]
DRAP recall ⚠️Substandard Medicines⚕️-27 June-2025 The Directorate of Drug Control (DDC) Punjab has notify DRAP (drug regulatory authority of Pakistan) […]
DRAP RECALL ⚠️The PRODUCTS CONTAINING HYDROXYPROGESTERONE CAPROATE💉 DRAP (Drug regulatory authority of Pakistan has recalled and suspends the registration of
DRAP Recalls: Substandard Medicine : Famobex Suspension by Cibex (Pvt.) Ltd. The Drug Regulatory Authority of Pakistan (DRAP) has issued
DRAP Recall Alert⚠️Recall of Substandard “Tovir 0.5mg Tablet” having Batch No. 55, Manufactured by M/s Adamjee Pharmaceuticals (Pvt.) Ltd, Karachi.
FDA approves ✔️ Tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL) On June 18, 2025, The FDA has approved tafasitamab-cxix
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews GRAND RAPIDS, Mich. – Meijer has issued
DRAP’s Action on Medroxyprogesterone Acetate in Response to Meningioma Concerns and US Lawsuits Amid the ongoing lawsuits in the US
DRAP RECALL ALERT-JUNE 2025 Drug regulatory authority of Pakistan (DRAP) is responsible for the regulation of drugs and therapeutic drugs
FDA approves Darolutamide for metastatic castration-sensitive prostate cancer FDA approves darolutamide for metastatic castration-sensitive prostate cancer on june 3, 2025.
VigiMobile app, a smart way to report ADR| Core of medical profession- essential to be known by every healthcare professional| Also get to known how to download the App.